title: Proposed: a standard clinical engineering review procedure.
abstract: Those overseeing clinical engineering (CE) functions at the top policy level--the Food and Drug Administration (FDA), the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), and others in the profession--depend on sporadic assessments of nonstandard samplings of data when analyzing CE functions such as maintenance compliance, risk and failure analysis, and inventory management. This methodology results in the following: a fragmented view of operational functions, a limited view of the interrelationships of CE functions, and policies that reflect assumptions of equipment reliability.
authors.affiliation: apakaln@commonsensedirections.org
authors.forename: Alan
authors.initials: A
authors.lastname: Pakaln
mesh_terms: D000068:Accreditation; D001698:Biomedical Engineering / Q000295:instrumentation / Q000379:methods / Q000592:standards*; D006761:Hospitals; D007591:Joint Commission on Accreditation of Healthcare Organizations; D010043:Outcome and Process Assessment, Health Care; D019984:Quality Indicators, Health Care; D017749:Total Quality Management; D014481:United States